Commentary on: Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries

被引：0
|
作者：
Juste Aristide Goungounga
Roch Giorgi
机构：
[1] Aix Marseille Univ,
[2] INSERM,undefined
[3] IRD,undefined
[4] SESSTIM,undefined
[5] Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale,undefined
[6] APHM,undefined
[7] Hôpital de la Timone,undefined
[8] Service Biostatistique et Technologies de l’Information et de la Communication,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：791 / 793
页数：2
相关论文
共 50 条
  • [31] A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172) (vol 52, pg 394, 2011)
    Kouroukis, C. Tom
    Fernandez, Louis A. V.
    Crump, Michael
    Gascoyne, Randy D.
    Chua, Neil Sun
    Buckstein, Rena
    Turner, Robert
    Assouline, Sarit
    Klasa, Richard J.
    Walsh, Wendy
    Powers, Jean
    Eisenhauer, Elizabeth
    LEUKEMIA & LYMPHOMA, 2011, 52 (06) : 1160 - 1160
  • [32] The Addition of Rituximab to CHOP Improves Failure-Free and Overall Survival of Mantle-Cell Lymphoma Patients - a Pooled Trials Analysis of the German Low-Grade Lymphoma Study Group (GLSG)
    Hoster, Eva
    Unterhalt, Michael
    Pfreundschuh, Michael
    Hallek, Michael
    Forstpointner, Roswitha
    Metzner, Bernd
    Einsele, Hermann
    Krauter, Juergen
    Duehrsen, Ulrich
    Ludwig, Wolf-Dieter
    Birkmann, Josef
    Peter, Norma
    Klapper, Wolfram
    Dreyling, Martin H.
    Hiddemann, Wolfgang
    BLOOD, 2014, 124 (21)
  • [33] Incidence and survival of gastric non-Hodgkin's lymphoma: A population-based study from the Association of the French Cancer Registries (FRANCIM)
    Danzon, Arlette
    Belot, Aurelien
    Maynadie, Marc
    Remontet, Laurent
    Dupont, Anne Claire Gossart
    Carbonnel, Franck
    ACTA ONCOLOGICA, 2009, 48 (07) : 977 - 983
  • [34] RELATIONSHIP BETWEEN OVERALL RESPONSE RATE (ORR), PROGRESSION-FREE SURVIVAL (PFS), AND OVERALL SURVIVAL (OS) IN CLINICAL TRIALS OF PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)
    Jen, M. H.
    Sonksen, M.
    Hess, L.
    Bian, F.
    VALUE IN HEALTH, 2023, 26 (06) : S44 - S44
  • [35] Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†
    Obr, Ales
    Prochazka, Vit
    Papajik, Tomas
    Klener, Pavel, Jr.
    Janikova, Andrea
    Salek, David
    Belada, David
    Pytlik, Robert
    Sykorova, Alice
    Mocikova, Heidi
    Simkovic, Martin
    Campr, Vit
    Dlouha, Jitka
    Furst, Tomas
    Trneny, Marek
    LEUKEMIA & LYMPHOMA, 2019, 60 (03) : 748 - 755
  • [36] Mantle Cell Lymphoma Prognostic Index and proliferative activity are strong prognostic markers in clinical practice: A retrospective study on 235 patients of the Czech Lymphoma Study Group
    Boudova, L.
    Vesela, P.
    Salek, D.
    Vokurka, S.
    Moulis, M.
    Kodet, R.
    Velenska, Z.
    Stritesky, J.
    Vernerova, Z.
    Trneny, M.
    Michal, M.
    VIRCHOWS ARCHIV, 2012, 461 : S20 - S20
  • [37] Allogeneic stem cell transplantation for mantle cell lymphoma—final report from the prospective trials of the East German Study Group Haematology/Oncology (OSHO)
    William H. Krüger
    Carsten Hirt
    Nadezda Basara
    Herbert G. Sayer
    Gerhard Behre
    Thomas Fischer
    Norbert Grobe
    Georg Maschmeyer
    Dietger Niederwieser
    Gottfried Dölken
    Annals of Hematology, 2014, 93 : 1587 - 1597
  • [38] Evaluation of the representativeness and generalizability of Japanese clinical trials for localized rectal/colon cancer: Comparing participants in the Japan Clinical Oncology Group study with patients in Japanese registries
    Miyamoto, Kenichi
    Wakabayashi, Masashi
    Mizusawa, Junki
    Nakamura, Kenichi
    Katayama, Hiroshi
    Higashi, Takahiro
    Inomata, Masafumi
    Kitano, Seigo
    Fujita, Shin
    Kanemitsu, Yukihide
    Fukuda, Haruhiko
    EJSO, 2020, 46 (09): : 1642 - 1648
  • [39] Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21
    Clark, Gary M.
    Zborowski, Denni M.
    Santabarbara, Pedro
    Ding, Keyue
    Whitehead, Marlo
    Seymour, Lesley
    Shepherd, Frances A.
    CLINICAL LUNG CANCER, 2006, 7 (06) : 389 - 394
  • [40] Clinical, Metabolic and Molecular Responses After 4 Courses of R-DHAP and After Autologous Stem Cell Transplantation for Untreated Mantle Cell Lymphoma Patients Included in the LyMa Trial, a Lysa Study
    Le Gouill, Steven
    Callanan, Mary
    Macintyre, Elizabeth
    Delfau-larue, Marie-helene
    Bodet-milin, Caroline
    Meignan, Michel
    Moreau, Anne
    Travers-Glehen, Alexandra
    Bene, Marie-christine
    Haouin, Corinne
    Gressin, Remy
    Casasnovas, Rene-Olivier
    Ribrag, Vincent
    Damaj, Gandhi
    Gyan, Emmanuel
    Oberic, Lucie
    Bouabdallah, Krimo
    Thieblemont, Catherine
    Hermine, Olivier
    BLOOD, 2012, 120 (21)
12345